Valuation: Cosmos Health Inc.

Market Cap 12.41M 10.72M 10.07M 9.16M 17.23M 1.19B 17.51M 118M 46.15M 594M 46.6M 45.59M 1.98B P/E 2026 *
21.8x
P/E 2027 * 3.11x
Enterprise Value 12.41M 10.72M 10.07M 9.16M 17.23M 1.19B 17.51M 118M 46.15M 594M 46.6M 45.59M 1.98B EV / Sales 2026 *
0.15x
EV / Sales 2027 * 0.11x
Free-Float
63.51%
Yield 2026 *
-
Yield 2027 * -
1 day+5.52%
1 week-6.48%
Current month+1.07%
1 month-21.76%
3 months-27.75%
6 months-43.15%
Current year-56.24%
1 week 0.2
Extreme 0.2039
0.25
1 month 0.18
Extreme 0.1773
0.28
Current year 0.16
Extreme 0.1616
0.59
1 year 0.16
Extreme 0.1616
1.32
3 years 0.16
Extreme 0.1616
2.05
5 years 0.16
Extreme 0.1616
150
10 years 0.16
Extreme 0.1616
312.5
Manager TitleAgeSince
Chief Executive Officer 60 26/02/2016
Director of Finance/CFO 43 11/11/2020
Chief Operating Officer 56 01/02/2023
Director TitleAgeSince
Director/Board Member 58 13/01/2014
Chairman 60 26/02/2016
Director/Board Member 59 18/11/2016
Date Insider Type Main position Quantity % Market Cap.
7/30/26 A Buy

Chief Executive Officer

349,825 1.1578%
7/29/26 A Free

Chief Financial Officer

328,407 1.0869%
7/29/26 A Buy

Chief Executive Officer

766,284 2.5362%
Change 5-day change 1-year change 3-year change Capi.($)
+5.52%-6.48%-75.66%-83.24% 12.41M
+1.44%-0.07%+29.11%+101.67% 101B
+1.70%-0.52%+57.19%+159.66% 54.69B
0.00%0.00%+4.93%+272.50% 24.3B
-1.13%-0.66%-11.80%-15.66% 8.24B
+0.54%+2.52%-30.90%-25.61% 7.73B
-0.24%-1.53%-14.67%-21.04% 6.64B
+1.24%+2.26%+8.86%+18.90% 6.33B
+0.31%-1.34%-2.99%+14.06% 4.98B
-0.59%+1.40%-5.24%-7.13% 3.74B
Average +0.88%-1.21%-4.12%+41.41% 21.8B
Weighted average by Cap. +1.10%-0.33%+26.54%+116.30%

Financials

2026 *2027 *
Net sales 84.3M 72.81M 68.42M 62.22M 117M 8.06B 119M 802M 313M 4.04B 317M 310M 13.41B 111M 95.7M 89.93M 81.78M 154M 10.59B 156M 1.05B 412M 5.31B 416M 407M 17.63B
Net income - -
Net Debt - -
Logo Cosmos Health Inc.
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Employees
163
Date Price Change Volume
14/08/26 $0.2179 +5.52% 953,969
13/08/26 $0.2065 -0.29% 1,406,018
12/08/26 $0.2071 -5.78% 1,961,585
11/08/26 $0.2198 -1.66% 1,890,531
10/08/26 $0.2235 -4.08% 3,862,758

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. COSM Stock